memantine has been researched along with sb 742457 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badange, RK; Bandyala, TR; Benade, V; Bhatta, V; Bhyrapuneni, G; Bojja, K; Goyal, V; Jasti, V; Jayarajan, P; Kambhampati, RS; Mohammed, AR; Nirogi, R; Palacharla, RC; Reballi, V; Saraf, SK; Shinde, A; Subramanian, R | 1 |
1 other study(ies) available for memantine and sb 742457
Article | Year |
---|---|
Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT
Topics: Administration, Oral; Alzheimer Disease; Animals; Drug Discovery; Humans; Indoles; Male; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists | 2017 |